GREENLIGHT BIOSCIENCES
GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower cost and more quickly than was ever before possible. GreenLight develops RNA products and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, plant protection and support the health of bees and other pollinators.
GREENLIGHT BIOSCIENCES
Industry:
Agriculture AgTech Biotechnology Life Science
Founded:
2008-01-01
Address:
Medford, Massachusetts, United States
Country:
United States
Website Url:
http://www.greenlightbiosciences.com
Total Employee:
251+
Status:
Active
Contact:
1(617)-616-8188
Email Addresses:
[email protected]
Total Funding:
449.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
Botanical Solutions
Botanical Solutions is a startup company that manufactures plant-based active ingredients and products from advanced botanicals.
Deepak Fertilisers
Deepak Fertilisers is a manufacturing agency that produces fertilizers and industrial chemicals.
Believer Meats
Believer Meats is a food technology company focused on using clean meat and cellular agriculture to replace traditional animal-based foods.
Hikal Ltd.
Hikal specializes in Custom Synthesis and Contract Manufacturing of Agrochemicals, Intermediates and Specialty Chemicals.
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Symbiosis Group
Symbiosis Group investment in Post-IPO Equity - Greenlight Biosciences
Insud Pharma
Insud Pharma investment in Post-IPO Equity - Greenlight Biosciences
BNP Paribas Asset Management
BNP Paribas Asset Management investment in Post-IPO Equity - Greenlight Biosciences
Rivas Capital
Rivas Capital investment in Post-IPO Equity - Greenlight Biosciences
Continental Grain Company
Continental Grain Company investment in Post-IPO Equity - Greenlight Biosciences
Cummings Foundation
Cummings Foundation investment in Post-IPO Equity - Greenlight Biosciences
S2G Ventures
S2G Ventures investment in Post-IPO Equity - Greenlight Biosciences
FTX Foundation
FTX Foundation investment in Post-IPO Equity - Greenlight Biosciences
Morningside Venture Investments
Morningside Venture Investments investment in Post-IPO Equity - Greenlight Biosciences
Fall Line Capital
Fall Line Capital investment in Post-IPO Equity - Greenlight Biosciences
Key Employee Changes
Official Site Inspections
http://www.greenlightbiosciences.com Semrush global rank: 3.06 M Semrush visits lastest month: 5.28 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Greenlight Biosciences"
Greenlight Biosciences - Crunchbase Company Profile …
Aug 12, 2013 Contact Email [email protected] Phone Number 1(617)-616-8188 GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower …See details»
GreenLight Biosciences - PitchBook
Information on acquisition, funding, investors, and executives for GreenLight Biosciences. Use the PitchBook Platform to explore the full profile.See details»
RNA Technology in Agriculture | GreenLight Biosciences
Jun 28, 2024 Explore GreenLight Biosciences' innovative RNA technology in agriculture platform, designed to produce food and replace chemical pesticides. Learn more today!See details»
GreenLight Biosciences - LinkedIn
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of nature to develop and commercialize effective, easy-to-use, and environmentally friendly crop protection ...See details»
GreenLight Biosciences Enters into Definitive Merger …
May 30, 2023 GreenLight Biosciences GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction LEXINGTON, Mass., May 30, 2023 ...See details»
GreenLight Biosciences Enters into Definitive Merger Agreement …
May 30, 2023 --GreenLight Biosciences Holdings, PBC today announced that the Company has entered into a definitive agreement to be acquired by a group of buyers led by Fall Line …See details»
Our Agritech Company Story - GreenLight Biosciences
Discover the story behind GreenLight Biosciences, an agritech company. We use RNA technology to create safer and sustainable food systems. Learn more today!See details»
GreenLight Biosciences Announces Business …
Aug 10, 2021 BOSTON--(BUSINESS WIRE)--GreenLight Biosciences, Inc.. ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and ...See details»
The reason we exist - GreenLight Biosciences
We already have a lot to be proud of as it relates to ED&I. Women and minorities are well-represented throughout the organization. According to the 2021 US census, women represent just 27% percent of the STEM workforce in the US, …See details»
GreenLight Biosciences opens RNA production facility …
Sep 23, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health,...See details»
GreenLight Biosciences Outlines Development Strategy and
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential...See details»
GreenLight Biosciences Outlines Development Strategy and …
Mar 7, 2023 GreenLight R&D day GreenLight is actively preparing for commercial launch prior to end of 2023 of our leading dsRNA solution, Calantha™, subject to regulatory approval. …See details»
GreenLight Biosciences and Epivax Therapeutics Sign
Sep 1, 2023 Investors and others should note that we communicate with our investors and the public using our website (www.greenlightbiosciences.com), the investor relations website …See details»
GreenLight Biosciences and Samsung Biologics announce …
Nov 24, 2021 For more information, visit https://www.greenlightbiosciences.com. In August 2021 , GreenLight Biosciences announced plans to become publicly listed through a business …See details»
GreenLight Biosciences and Samsung Biologics complete first …
Aug 1, 2022 GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities; Technology transfer and scale-up from lab bench to Samsung's …See details»
GreenLight Biosciences Outlines Development Strategy and …
Mar 9, 2023 GreenLight human health day image GreenLight today outlines its pipeline strategy and R&D progress for mRNA-based solutions during its Human Health R&D Day -- …See details»
Our ESG commitment - GreenLight Biosciences
IAVI, a nonprofit scientific research organization, will advance our messenger RNA COVID-19 vaccine candidate in a Phase I clinical trial with research partners in sub-Saharan Africa. We …See details»
Join our team - GreenLight Biosciences
We’re looking for the world’s best biologists, chemists, and engineers to help us solve some of the world’s most pressing challenges. GreenLight Bio is dedicated to revolutionizing the …See details»
The world is in peril and aching for solutions
We are united by sustainability. Environmental and social impact is inherent to our purpose and the underlying reason our company was launched. We were founded to develop sustainable …See details»